CopyMark Law Group
4.9/5
Drawing for GCSA THE GLOBAL QUALITY STANDARD FOR CLINICAL RESEARCH SITES

USPTO serial 79398938

GCSA THE GLOBAL QUALITY STANDARD FOR CLINICAL RESEARCH SITES

Reviewed by CopyMark Law Group

Reg. 7781269Status 700Registered
Filing date
Status date
Registration date
May 6, 2025
Examiner
ARRISON, RACHEL MARIE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GCSA THE GLOBAL QUALITY STANDARD FOR CLINICAL RESEARCH SITES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bradley M. Stohry

Bradley M. Stohry Reichel Stohry Dean LLP6151 Central AveIndianapolis, IN 46220United States

Goods and services

ClassDescriptionStatusFirst use
042Testing, analysis, auditing, and evaluation of the services of others to determine conformity with certification standards in the field of clinical trials and clinical trial site competency, practices and processes; providing quality assurance services in the field of clinical trials and clinical trial site competency, practices and processes; quality control for others in the nature of quality checking in the field of clinical trial site competency, practices and processes; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of clinical trial site competency, practices and processes; information, advisory and consultancy in the field of certification standards of clinical trials, clinical trial site competency, practices and processes; information, advisory and consultancy services in the field of quality assurance services of clinical trials, clinical trial site competency, practices and processes; information, advisory and consultancy services in the field of quality control of clinical trials, clinical trial site competency, practices and processes; information, advisory and consultancy services in the fields of quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, of clinical trial site competency, practices and processesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 25, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 18, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 4, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 3, 2025FIMPFINAL DISPOSITION PROCESSED—
Dec 3, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 3, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 6, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 6, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 6, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 18, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 18, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 12, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 24, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 21, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 21, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 21, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2024RFNTREFUSAL PROCESSED BY IB—
Oct 31, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 31, 2024RFRRREFUSAL PROCESSED BY MPU—
Oct 26, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 25, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2024DOCKASSIGNED TO EXAMINER—
Jul 10, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 10, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 4, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance